Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Notified Bodies, Authorized Reps And The CE Mark: How Does Post-Brexit Uncertainty Cloud Future MDR/IVDR?

This article was originally published in Clinica

Executive Summary

While the UK and the EU struggle to comprehend the full implications of the UK’s decision to leave the European Union, Amanda Maxwell considers the implications for the implementation of the future Medical Devices and IVD Regulations, including the question-mark that hangs over the future of UK notified bodies

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT103545

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel